Enzyme replacement therapy to treat alpha-mannosidosis
The EMA has recommended granting a marketing authorisation in the EU for Lamzede a long-term enzyme replacement therapy for alpha-mannosidosis...
List view / Grid view
The EMA has recommended granting a marketing authorisation in the EU for Lamzede a long-term enzyme replacement therapy for alpha-mannosidosis...
The EMA is launching a survey to gather information from companies on their Brexit preparedness plans and identify any particular concerns with regard to medicines supply that may impact public or animal health...
A drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus...
Scientists looking for jobs after completing their training may soon have a new tool that helps them evaluate various career paths...
Miniaturised system could be used to treat neurological disorders that affect specific brain regions...
A drug used to treat seizures may effectively treat the movement symptoms in people with dementia with Lewy bodies without causing additional psychiatric symptoms...
Treatment with a pharmaceutical formulation of cannabidiol alongside other anti-epilepsy treatments helped to reduce the number of drop seizures in people with Lennox-Gastaut syndrome...
Researchers find that vitamin D supplements could help to ease painful Irritable Bowel Syndrome symptoms...
Clinical trial will compare three antiretroviral drug regimens...
Researchers have shown how they utilise 3D bioprinting to control the distribution of melanocytes on a biomimetic tissue substrate, to produce human-like skin pigmentation...
The European Commission has issued Orphan Designation to gilteritinib for the treatment of patients with acute myeloid leukaemia...
Researchers have developed a universal vaccine to combat influenza A viruses that produces long-lasting immunity...
Addition of hydroxyurea to current chemotherapy significantly improved survival in animal models of glioblastoma...
Researchers in the emerging field of neuromorphic computing have attempted to design computer chips that work like the human brain...
The FDA has issued a Study may proceed letter for the first study in humans, thereby accepting the investigational new drug application for the drug candidate SOBI003...